{"id":448,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2020-10-01","marketCap":377.2349853515625,"name":"Pulmonx Corp","phone":"16509342600.0","outstanding":38.029998779296875,"symbol":"LUNG","website":"https://pulmonx.com/","industry":"Health Care"},"price":9.75,"year":2023,"month":11,"day":4,"weekday":"Saturday","title":"The Influence of ESG Factors on the Stock Price of Pulmonx Corp","date":"2023-11-04","url":"/posts/2023/11/04/LUNG","content":[{"section":"Introduction","text":"Pulmonx Corp, a leading medical device company specializing in lung health, has experienced significant impacts on its stock price due to ESG factors. ESG factors, which encompass environmental, social, and governance considerations, have become crucial metrics for investors to evaluate the long-term sustainability and ethical practices of companies. In recent years, investors have recognized the importance of ESG factors as indicators of financial performance and risk management, leading to a shift in investment decisions."},{"section":"Environmental Factors","text":"One significant ESG factor that affects Pulmonx Corp's stock price is its environmental impact. As a medical device company, Pulmonx Corp is expected to demonstrate a commitment to reducing its environmental footprint. Investors are increasingly concerned about companies' carbon emissions, waste management, and resource consumption. Pulmonx Corp's efforts in developing environmentally friendly products and implementing sustainable practices positively influence its stock price, as investors recognize the long-term benefits of environmentally responsible companies."},{"section":"Social Factors","text":"The social factors encompassing Pulmonx Corp's operations also have a substantial influence on its stock price. Social factors include the company's relationships with its employees, customers, and communities. Investors evaluate Pulmonx Corp's commitment to diversity and inclusion, employee satisfaction, and community engagement. A positive social impact enhances the company's reputation and brand value, which directly affects its stock price. Ethical business practices and strong social responsibility initiatives are increasingly attractive to investors seeking sustainable long-term growth."},{"section":"Governance Factors","text":"Governance factors play a critical role in shaping investor decisions regarding Pulmonx Corp's stock. Good governance practices, such as transparent and accountable leadership, effective risk management, and responsible executive compensation, are vital considerations for investors. Pulmonx Corp's adherence to strong corporate governance principles instills confidence among investors, as it demonstrates a commitment to ethical decision-making and long-term value creation. Companies with robust governance structures are more likely to attract and retain investors, positively impacting their stock price."},{"section":"Shaping Investor Decisions","text":"ESG considerations are increasingly shaping investor decisions, leading to a greater emphasis on long-term value and sustainability. Investors recognize that companies that prioritize ESG factors are better equipped to mitigate risks and adapt to changing environmental and social landscapes. Pulmonx Corp's focus on ESG factors not only contributes to its financial performance but also aids in building investor trust. By aligning their investment strategies with ESG principles, investors aim to generate returns while supporting companies that promote a more sustainable and responsible future."},{"section":"Conclusion","text":"Pulmonx Corp's stock price is significantly influenced by ESG factors, including environmental, social, and governance considerations. Investors now examine beyond financial statements and analyze a company's impact on the environment, society, and its governance practices. The integration of ESG metrics into investment decisions fosters a more sustainable and responsible investment landscape. As the importance of ESG factors continues to grow, Pulmonx Corp recognizes that prioritizing ESG considerations not only contributes to its financial success but also attracts conscientious investors committed to a more sustainable future."}],"tags":["CrossUnder200","Short","Health Care"],"news":[{"category":"company","date":1698798902,"headline":"Canaccord Genuity Maintains Pulmonx (LUNG) Buy Recommendation","id":123535411,"image":"","symbol":"LUNG","publisher":"Fintel","summary":"","url":"https://fintel.io/news/canaccord-genuity-maintains-pulmonx-lung-buy-recommendation-277"},{"category":"company","date":1698798901,"headline":"Piper Sandler Maintains Pulmonx (LUNG) Overweight Recommendation","id":123535412,"image":"","symbol":"LUNG","publisher":"Fintel","summary":"","url":"https://fintel.io/news/piper-sandler-maintains-pulmonx-lung-overweight-recommendation-225"},{"category":"company","date":1698782700,"headline":"Pulmonx to Participate at Upcoming Investor Conferences","id":123537285,"image":"https://media.zenfs.com/en/globenewswire.com/95b276d00fa1b3e0eb1a5ec7582a20e3","symbol":"LUNG","publisher":"Yahoo","summary":"REDWOOD CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in two upcoming investor conferences. Pulmonx management is scheduled to participate in a fireside chat at the Stifel 2023 Healthcare Conference in New York on Tuesday, November 14, 2023, at 11:25am PT / 2:25pm ET. Interested parties may access a live and archived webcast","url":"https://finance.yahoo.com/news/pulmonx-participate-upcoming-investor-conferences-200500412.html"},{"category":"company","date":1698757201,"headline":"Pulmonx Corporation (NASDAQ:LUNG) Q3 2023 Earnings Call Transcript","id":123521141,"image":"https://media.zenfs.com/en/insidermonkey.com/237bf7d81774053ae7a1d6a31c84b22a","symbol":"LUNG","publisher":"Yahoo","summary":"Pulmonx Corporation (NASDAQ:LUNG) Q3 2023 Earnings Call Transcript October 30, 2023 Pulmonx Corporation beats earnings expectations. Reported EPS is $-0.39, expectations were $-0.45. Operator: Thank you for standing by. Welcome to the Pulmonx Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will […]","url":"https://finance.yahoo.com/news/pulmonx-corporation-nasdaq-lung-q3-130001207.html"},{"category":"company","date":1698755880,"headline":"Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session","id":123524280,"image":"","symbol":"LUNG","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3187370079"},{"category":"company","date":1698750300,"headline":"Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday","id":123522419,"image":"","symbol":"LUNG","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3187220546"},{"category":"company","date":1698750234,"headline":"Q3 2023 Pulmonx Corp Earnings Call","id":123521142,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"LUNG","publisher":"Yahoo","summary":"Q3 2023 Pulmonx Corp Earnings Call","url":"https://finance.yahoo.com/news/q3-2023-pulmonx-corp-earnings-110354086.html"},{"category":"company","date":1698740220,"headline":"Pulmonx (LUNG) Receives a Buy from Craig-Hallum","id":123522929,"image":"","symbol":"LUNG","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3186962908"},{"category":"company","date":1698731520,"headline":"Pulmonx price target lowered to $12 from $20 at Canaccord","id":123522931,"image":"","symbol":"LUNG","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3186781259"},{"category":"company","date":1698730620,"headline":"Piper Sandler Sticks to Their Buy Rating for Pulmonx (LUNG)","id":123522932,"image":"","symbol":"LUNG","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3186766513"},{"category":"company","date":1698725460,"headline":"Analysts Conflicted on These Healthcare Names: Revvity (RVTY), Pulmonx (LUNG) and Roche Holding AG (OtherRHHVF)","id":123522935,"image":"","symbol":"LUNG","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3186693213"},{"category":"company","date":1698705007,"headline":"Pulmonx Corporation (LUNG) Reports Q3 Loss, Tops Revenue Estimates","id":123513053,"image":"https://media.zenfs.com/en/zacks.com/ace7df31c7fcb10255abe7c990ea373a","symbol":"LUNG","publisher":"Yahoo","summary":"Pulmonx Corporation (LUNG) delivered earnings and revenue surprises of 13.33% and 10.67%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?","url":"https://finance.yahoo.com/news/pulmonx-corporation-lung-reports-q3-223007323.html"},{"category":"company","date":1698702816,"headline":"Pulmonx Corp (LUNG) Reports Record Q3 2023 Financial Results","id":123513054,"image":"","symbol":"LUNG","publisher":"Yahoo","summary":"Revenue and U.S. sales hit record highs, with a 31% and 41% increase respectively","url":"https://finance.yahoo.com/news/pulmonx-corp-lung-reports-record-215336244.html"},{"category":"company","date":1698698229,"headline":"Pulmonx Corporation (LUNG) Q3 2023 Earnings Call Transcript","id":123511732,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"LUNG","publisher":"SeekingAlpha","summary":"Pulmonx Corporation (NASDAQ:NASDAQ:LUNG) Q3 2023 Earnings Conference Call October 30, 2023 4:30 PM ETCompany ParticipantsDorothy Morgan - Investor...","url":"https://seekingalpha.com/article/4645182-pulmonx-corporation-lung-q3-2023-earnings-call-transcript"},{"category":"company","date":1698696300,"headline":"Pulmonx Reports Record Third Quarter 2023 Financial Results","id":123513055,"image":"https://media.zenfs.com/en/globenewswire.com/95b276d00fa1b3e0eb1a5ec7582a20e3","symbol":"LUNG","publisher":"Yahoo","summary":"REDWOOD CITY, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the \"Company\"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the third quarter of 2023 ended September 30, 2023. Recent Highlights Achieved record worldwide revenue of $17.7 million in the third quarter of 2023, a 31% increase over the same period last year and an increase of 29% on a constant currency basisDelivered a record $11.8 mi","url":"https://finance.yahoo.com/news/pulmonx-reports-record-third-quarter-200500677.html"},{"category":"company","date":1698687900,"headline":"Pulmonx Shares Climb 17% as it Raises FY Guidance","id":123508845,"image":"https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png","symbol":"LUNG","publisher":"MarketWatch","summary":"By Sabela Ojea Shares of Pulmonx climbed 17% to $9.23 in after-hours trading after the company raised its revenue expectations for the year. The developer of...","url":"https://www.marketwatch.com/story/pulmonx-shares-climb-17-as-it-raises-fy-guidance-612e4128"},{"category":"company","date":1698670500,"headline":"Commit To Buy Pulmonx At $7.50, Earn 24.3% Annualized Using Options","id":123507341,"image":"","symbol":"LUNG","publisher":"Stock Options Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3185397643"},{"category":"company","date":1698645540,"headline":"Fly Intel: After-Hours Movers","id":123509476,"image":"","symbol":"LUNG","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3185905696"},{"category":"company","date":1698642780,"headline":"Earnings Scheduled For October 30, 2023","id":123496945,"image":"","symbol":"LUNG","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3184826513"},{"category":"company","date":1698636960,"headline":"Pulmonx GAAP EPS of -$0.39 beats by $0.04, revenue of $17.7M beats by $1.03M","id":123507345,"image":"","symbol":"LUNG","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3185647436"},{"category":"company","date":1698635340,"headline":"Pulmonx sees FY23 revenue $67M-$68M, consensus $65.95M","id":123507347,"image":"","symbol":"LUNG","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3185602122"},{"category":"company","date":1698635340,"headline":"Pulmonx reports Q3 EPS (39c), consensus (43c)","id":123507346,"image":"","symbol":"LUNG","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3185602115"},{"category":"company","date":1698368880,"headline":"Pulmonx Earnings Preview","id":123462390,"image":"","symbol":"LUNG","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3181711240"}]}